Cargando…

Assessment of industry data on pulmonary and immunosuppressive effects of IQOS

INTRODUCTION: Heated tobacco products are being touted as novel reduced-harm tobacco products by tobacco companies. In the USA, Philip Morris International submitted a modified risk tobacco product (MRTP) application to the US Food and Drug Administration in 2016 in which it purports that its heated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moazed, Farzad, Chun, Lauren, Matthay, Michael A, Calfee, Carolyn S, Gotts, Jeffrey
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252496/ https://www.ncbi.nlm.nih.gov/pubmed/30158203 http://dx.doi.org/10.1136/tobaccocontrol-2018-054296

Ejemplares similares

Possible hepatotoxicity of IQOS
por: Chun, Lauren, et al.
Publicado: (2018)

IQOS labelling will mislead consumers
por: McKelvey, Karma, et al.
Publicado: (2018)

Revolution or redux? Assessing IQOS through a precursor product
por: Elias, Jesse, et al.
Publicado: (2018)

IQOS campaign in Israel
por: Rosen, Laura J, et al.
Publicado: (2018)

IQOS: examination of Philip Morris International’s claim of reduced exposure
por: St.Helen, Gideon, et al.
Publicado: (2018)

Heated tobacco products: the example of IQOS
por: Glantz, Stanton A
Publicado: (2018)

Categorizing IQOS-Related Twitter Discussions
por: Barker, Joshua O., et al.
Publicado: (2021)

Examining perceptions about IQOS heated tobacco product: consumer studies in Japan and Switzerland
por: Hair, Elizabeth C, et al.
Publicado: (2018)

Factors that influence smokers’ and ex-smokers’ use of IQOS: a qualitative study of IQOS users and ex-users in the UK
por: Tompkins, Charlotte N E, et al.
Publicado: (2021)

Brief report on IQOS point-of-sale marketing, promotion and pricing in IQOS retail partner stores in Atlanta, Georgia, USA
por: Henderson, Katherine C, et al.
Publicado: (2023)

Aerosolized nicotine from e-cigarettes alters gene expression, increases lung protein permeability, and impairs viral clearance in murine influenza infection
por: Maishan, Mazharul, et al.
Publicado: (2023)

Anticipating IQOS market expansion in the United States
por: Abroms, Lorien, et al.
Publicado: (2022)

Potential Harm of IQOS Smoke to Rat Liver
por: Granata, Silvia, et al.
Publicado: (2023)

PMI’s own in vivo clinical data on biomarkers of potential harm in Americans show that IQOS is not detectably different from conventional cigarettes
por: Glantz, Stanton A
Publicado: (2018)

Tobacco-specific nitrosamines (TSNA) in heated tobacco product IQOS
por: Leigh, Noel J, et al.
Publicado: (2018)

Risk perception of IQOS™ and cigarettes: Temporal and cross-country comparisons
por: AlMoosawi, Suzana, et al.
Publicado: (2022)

Comparison of thermodilution measured extravascular lung water with chest radiographic assessment of pulmonary oedema in patients with acute lung injury
por: Brown, Lisa M, et al.
Publicado: (2013)

IQOS point-of-sale marketing strategies in Israel: a pilot study
por: Bar-Zeev, Yael, et al.
Publicado: (2019)

Treatment for severe acute respiratory distress syndrome from COVID-19
por: Matthay, Michael A, et al.
Publicado: (2020)

Vascular endothelial function is impaired by aerosol from a single IQOS HeatStick to the same extent as by cigarette smoke
por: Nabavizadeh, Pooneh, et al.
Publicado: (2018)

‘Green Zing’ and a selection of color concept descriptors on IQOS HEETS in Mexico
por: Grilo, Graziele, et al.
Publicado: (2022)

Corporate communication of the relative health risks of IQOS through a webchat service
por: Braznell, Sophie, et al.
Publicado: (2023)

Awareness, experience and prevalence of heated tobacco product, IQOS, among young Korean adults
por: Kim, Jinyoung, et al.
Publicado: (2018)

Informing iQOS Regulations in the United States: A Synthesis of What We Know
por: Berg, Carla J., et al.
Publicado: (2020)

Comparing the Characteristics of Cigarette Smoking and e-Cigarette and IQOS Use among Adolescents in Taiwan
por: Lee, Yue-Chune, et al.
Publicado: (2020)

Should IQOS Emissions Be Considered as Smoke and Harmful to Health? A Review of the Chemical Evidence
por: Uguna, Clement N., et al.
Publicado: (2022)

IQOS Use and Interest by Sociodemographic and Tobacco Behavior Characteristics among Adults in the US and Israel
por: Levine, Hagai, et al.
Publicado: (2023)

IQOS debut in the USA: Philip Morris International’s heated tobacco device introduced in Atlanta, Georgia
por: Churchill, Victoria, et al.
Publicado: (2020)

Awareness and interest in IQOS heated tobacco products among youth in Canada, England & the United States.
por: Czoli, Christine D., et al.
Publicado: (2019)

Modelling the impact of a new tobacco product: review of Philip Morris International’s Population Health Impact Model as applied to the IQOS heated tobacco product
por: Max, Wendy B, et al.
Publicado: (2018)

The effects of dual IQOS and cigarette smoke exposure on airway epithelial cells: implications for lung health and respiratory disease pathogenesis
por: Saha, Pritam, et al.
Publicado: (2023)

IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette
por: Sohal, Sukhwinder Singh, et al.
Publicado: (2019)

Comparison of 3R4F cigarette smoke and IQOS heated tobacco product aerosol emissions
por: Kärkelä, Teemu, et al.
Publicado: (2021)

Cathepsin L Helps to Defend Mice from Infection with Influenza A
por: Xu, Xiang, et al.
Publicado: (2016)

Household Surveys in the General Population and Web-Based Surveys in IQOS Users Registered at the Philip Morris International IQOS User Database: Protocols on the Use of Tobacco- and Nicotine-Containing Products in Germany, Italy, and the United Kingdom (Greater London), 2018-2020
por: Sponsiello-Wang, Zheng, et al.
Publicado: (2019)

Delayed angiopoietin‐2 blockade reduces influenza‐induced lung injury and improves survival in mice
por: Gotts, Jeffrey E., et al.
Publicado: (2021)

Pharmacokinetic and subjective assessment of prototype JUUL2 electronic nicotine delivery system in two nicotine concentrations, JUUL system, IQOS, and combustible cigarette
por: Goldenson, Nicholas I., et al.
Publicado: (2022)

Nicotine Delivery and User Ratings of IQOS Heated Tobacco System Compared With Cigarettes, Juul, and Refillable E-Cigarettes
por: Phillips-Waller, Anna, et al.
Publicado: (2021)

United States Food and Drug Administration’s authorization of reduced exposure claims for IQOS(®): implications for regulation in Latin America
por: Eckford, Robert, et al.
Publicado: (2022)

IQOS(TM) vs. e-Cigarette vs. Tobacco Cigarette: A Direct Comparison of Short-Term Effects after Overnight-Abstinence
por: Adriaens, Karolien, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ga0c3gfbkl9r0c71eu9huuk8sc